ArticleCancers2021

Co-Treatment with the Epigenetic Drug, 3-Deazaneplanocin A (DZNep) and Cisplatin after DZNep Priming Enhances the Response to Platinum-Based Therapy in Chondrosarcomas.

Eva Lhuissier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.